Table of Contents
Metal-Based Drugs
Volume 2008 (2008), Article ID 469531, 19 pages
http://dx.doi.org/10.1155/2008/469531
Research Article

Synthetic Polymers as Drug-Delivery Vehicles in Medicine

School of Chemistry, University of the Witwatersrand, Private Bag 3, WITS 2050, Johannesburg, South Africa

Received 13 August 2007; Accepted 18 October 2007

Academic Editor: Jannie C. Swarts

Copyright © 2008 Eberhard W. Neuse. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. L. Juliano, Ed., Biological Approaches to the Controlled Delivery of Drugs, R. L. Juliano, Ed., vol. 507, New York Academy of Sciences, New York, NY, USA, 1987.
  2. M. S. Sachdeva, “Drug targeting systems for cancer chemotherapy,” Expert Opinion on Investigational Drugs, vol. 7, no. 11, 1849 pages, 1998. View at Publisher · View at Google Scholar · View at PubMed
  3. R. Duncan, “The dawning era of polymer therapeutics,” Nature Reviews, Drug Discovery, vol. 2, 347 pages, 2003. View at Publisher · View at Google Scholar · View at PubMed
  4. H. Ringsdorf, “Structure and properties of pharmacologically active polymers,” Journal of Polymer Science: Polymer Symposia, vol. 51, 135 pages, 1975. View at Google Scholar
  5. J. Kopeček, “Smart and genetically engineered biomaterials and drug delivery systems,” European Journal of Pharmaceutical Sciences, vol. 20, no. 1, 1 pages, 2003. View at Publisher · View at Google Scholar
  6. D. W. Pack, A. S. Hoffman, S. Pun, and P. S. Stayton, “Design and development of polymers for gene delivery,” Nature Reviews, Drug Discovery, vol. 4, no. 7, 581 pages, 2005. View at Publisher · View at Google Scholar · View at PubMed
  7. R. Duncan and J. Kopeček, “Soluble synthetic polymers as potential drug carriers,” Advances in Polymer Science, vol. 57, 51 pages, 1984. View at Publisher · View at Google Scholar
  8. C. J. T. Hoes and J. Feijen, “The application of drug-polymer conjugates in chemotherapy,” in Drug Carrier Systems, F. H. D. Roerdink and A. M. Kroon, Eds., p. 57, John Wiley & Sons, New York, NY, USA, 1989. View at Google Scholar
  9. S. E. Matthews, C. W. Pouton, and M. D. Threadgill, “Macromolecular systems for chemotherapy and magnetic resonance imaging,” Advanced Drug Delivery Reviews, vol. 18, no. 2, 219 pages, 1996. View at Publisher · View at Google Scholar
  10. F. M. Veronese and M. Morpurgo, “Bioconjugation in pharmaceutical chemistry,” II Farmaco, vol. 54, no. 8, 497 pages, 1999. View at Publisher · View at Google Scholar
  11. H. Maeda, J. Wu, T. Sawa, Y. Matsumura, and K. Hori, “Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review,” Journal of Controlled Release, vol. 65, no. 1-2, 271 pages, 2000. View at Publisher · View at Google Scholar
  12. R. J. Christie and D. W. Grainger, “Design strategies to improve soluble macromolecular delivery constructs,” Advanced Drug Delivery Reviews, vol. 55, no. 3, 421 pages, 2003. View at Publisher · View at Google Scholar
  13. R. Duncan, M. J. Vicent, F. Greco, and R. I. Nicholson, “Polymer-drug conjugates: towards a novel approach for the treatment of endrocine-related cancer,” Endocrine-Related Cancer, vol. 12, S189 pages, 2005. View at Publisher · View at Google Scholar · View at PubMed
  14. A. Nori and J. Kopeček, “Intracellular targeting of polymer-bound drugs for cancer chemotherapy,” Advanced Drug Delivery Reviews, vol. 57, no. 4, 609 pages, 2005. View at Publisher · View at Google Scholar · View at PubMed
  15. P. Neri, G. Antoni, F. Benvenuti, F. Cocola, and G. Gazzei, “Synthesis of α,β-poly[(2-hydroxyethyl)-DL-aspartamide], a new plasma expander,” Journal of Medicinal Chemistry, vol. 16, no. 8, 893 pages, 1973. View at Publisher · View at Google Scholar
  16. J. Drobnik, V. Saudek, J. Vlasák, and J. Kálal, “Polyaspartamide—a potential drug carrier,” Journal of Polymer Science: Polymer Symposia, vol. 66, no. 1, 65 pages, 1979. View at Google Scholar
  17. J. Kálal, J. Drobnik, J. Kopeček, and J. Exner, “Water soluble polymers for medicine,” British Polymer Journal, vol. 10, no. 2, 111 pages, 1978. View at Publisher · View at Google Scholar
  18. P. Neri and G. Antoni, “α,β-poly(2-Hydroxyethyl)-DL-aspartamide,” Macromolecular Syntheses, vol. 8, 25 pages, 1982. View at Google Scholar
  19. M. de L. Machado, E. W. Neuse, and A. G. Perlwitz, “Water-soluble polyamides as potential drug carriers, V. Carboxy-functionalized polyaspartamides and copolyaspartamides,” Angewandte Makromolekulare Chemie, vol. 195, no. 1, 35 pages, 1992. View at Publisher · View at Google Scholar
  20. G. Caldwell, E. W. Neuse, and A. G. Perlwitz, “Water soluble polyamides as potential drug carriers. IX. Polyaspartamides grafted with amine-terminated poly(ethylene oxide) chains,” Journal of Applied Polymer Science, vol. 66, no. 5, 911 pages, 1997. View at Publisher · View at Google Scholar
  21. J. Pytela, V. Saudek, J. Drobník, and F. Rypáček, “Poly(N5 -hydroxyalkylglutamines). IV. Enzymatic degradation of n5-(2-hydroxyethyl)Lglutamine homopolymers and copolymers,” Journal of Controlled Release, vol. 10, no. 1, 17 pages, 1989. View at Publisher · View at Google Scholar
  22. F. Danusso and P. Ferruti, “Synthesis of tertiary amine polymers,” Polymer, vol. 11, no. 2, 88 pages, 1970. View at Publisher · View at Google Scholar
  23. P. Ferruti, M. A. Marchisio, and R. Duncan, “Poly(amido-amine)s: biomedical applications,” Macromolecular Rapid Communications, vol. 23, no. 5-6, 332 pages, 2002. View at Publisher · View at Google Scholar
  24. G. Caldwell, E. W. Neuse, and A. Stephanou, “Synthesis of water-soluble polyimidoamines for biomedical application. II. Polymers possessing intrachain-type secondary amino groups suitable for side-chain attachment,” Journal of Applied Polymer Science, vol. 50, no. 3, 393 pages, 1993. View at Publisher · View at Google Scholar
  25. D. D. N'Da and E. W. Neuse, “Polyamidoamines as drug carriers: synthesis of polymers featuring extrachain-type primary amino groups as drug-anchoring sites,” South African Journal of Chemistry, vol. 59, 65 pages, 2006. View at Google Scholar
  26. J. Kopeček and H. Bažilová, “Poly[N-(2-hydroxypropyl)methacrylamide]—I. Radical polymerization and copolymerization,” European Polymer Journal, vol. 9, no. 1, 7 pages, 1973. View at Publisher · View at Google Scholar
  27. J. Kopeček, P. Kopečková, T. Minko, and Z.-R. Lu, “HPMA copolymer-anticancer drug conjugates: design, activity, and mechanism of action,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 50, no. 1, 61 pages, 2000. View at Publisher · View at Google Scholar
  28. K. D. Jensen, A. Nori, M. Tijerina, P. Kopečková, and J. Kopeček, “Cytoplasmic delivery and nuclear targeting of synthetic macromolecules,” Journal of Controlled Release, vol. 87, no. 1-3, 89 pages, 2003. View at Publisher · View at Google Scholar
  29. O. Hovorka, T. Etrych, V. Šubr, J. Strohalm, K. Ulbrich, and B. Říhová, “HPMA based macromolecular therapeutics: internalization, intracellular pathway and cell death depend on the character of covalent bond between the drug and the peptidic spacer and also on spacer composition,” Journal of Drug Targeting, vol. 14, no. 6, 391 pages, 2006. View at Publisher · View at Google Scholar · View at PubMed
  30. E. W. Neuse and G. Caldwell, “cis-diaminedichloroplatinurn(II) complexes reversibly linked into the main chain of water-soluble polyamides,” Journal of Inorganic and Organometallic Polymers, vol. 7, no. 3, 163 pages, 1997. View at Publisher · View at Google Scholar
  31. J. C. Swarts, E. W. Neuse, A. G. Perlwitz, A. Stephanou, and G. J. Lamprecht, “Water-soluble polyamides as potential drug carriers, VI. Synthesis of amine- and carboxyl-functionalized carrier polymers by high-temperature solution polymerization in polyphosphoric acid,” Angewandte Makromolekulare Chemie, vol. 207, no. 1, 123 pages, 1993. View at Publisher · View at Google Scholar
  32. J. C. Dabrowiak and W. T. Bradner, “Platinum antitumour agents,” Progress in Medicinal Chemistry, vol. 24, 129 pages, 1987. View at Google Scholar
  33. T. W. Hambley, “The influence of structure on the activity and toxicity of Pt anti-cancer drugs,” Coordination Chemistry Reviews, vol. 166, 181 pages, 1997. View at Publisher · View at Google Scholar
  34. E. W. Neuse, “Platinum coordination compounds in cancer research and chemotherapy,” South African Journal of Science, vol. 95, no. 11-12, 509 pages, 1999. View at Google Scholar
  35. I. Kostova, “Platinum complexes as anticancer agents,” Recent Patents on Anti-Cancer Drug Delivery, vol. 1, no. 1, 1 pages, 2006. View at Google Scholar
  36. D. W. Siegmann-Louda and C. E. Carraher, Jr., “Platinum-containing polymers for the treatment of cancer,” in Macromolecules Containing Metal and Metal-Like Elements, Vol. 3, Biomedical Applications, A. S. Abd-El-Aziz, C. E. Carraher, Jr., C. U. Pittman, Jr., J. E. Sheats, and M. Zeldin, Eds., p. 119, John Wiley & Sons, New York, NY, USA, 2004, chapter 7. View at Google Scholar
  37. B. A. Howell and E. W. Walles, “cis-dichloro(substituted o-phenylenediamine)-platinum(II) compounds,” Inorganica Chimica Acta, vol. 142, no. 2, 185 pages, 1988. View at Publisher · View at Google Scholar
  38. E. W. Neuse, B. B. Patel, and C. W. N. Mbonyana, “cis-diaminedichloroplatinum(II) complexes reversibly bound to water-soluble polyaspartamide carriers for chemotherapeutic applications—I: platinum coordination to preformed, carrier-attached ethylenediamine ligands,” Journal of Inorganic and Organometallic Polymers, vol. 1, no. 2, 147 pages, 1991. View at Publisher · View at Google Scholar
  39. E. W. Neuse, G. Caldwell, and A. G. Perlwitz, “cis-diaminedichloroplatinum(II) complexes reversibly bound to water-soluble polyaspartamide carriers for chemotherapeutic applications—II: platinum coordination to ethylenediamine ligands attached to poly(ethylene oxide)-grafted carrier polymers,” Journal of Inorganic and Organometallic Polymers, vol. 5, no. 3, 195 pages, 1995. View at Publisher · View at Google Scholar
  40. C. W. N. Mbonyana, E. W. Neuse, and A. G. Perlwitz, “Monoamineplatinum (II) complexes conjugated to water-soluble carrier polymers for chemotherapeutic applications,” Applied Organometallic Chemistry, vol. 7, no. 4, 279 pages, 1993. View at Publisher · View at Google Scholar
  41. G. Caldwell, E. W. Neuse, and C. E. J. van Rensburg, “Cytotoxicity of selected water-soluble polymer-cis-diaminedichloroplatinum(II) conjugates against the human HeLa cancer cell line,” Journal of Inorganic and Organometallic Polymers, vol. 7, no. 4, 217 pages, 1997. View at Publisher · View at Google Scholar
  42. B. Schechter, G. Caldwell, M. G. Meirim, and E. W. Neuse, “Preliminary toxicological studies of selected water-soluble polymer-platinum conjugates,” Applied Organometallic Chemistry, vol. 14, no. 11, 701 pages, 2000. View at Publisher · View at Google Scholar
  43. E. Gianasi, R. G. Buckley, J. Latigo, M. Wasil, and R. Duncan, “HPMA copolymers platinates containing dicarboxylato ligands. Preparation, characterisation and in vitro and in vivo evaluation,” Journal of Drug Targeting, vol. 10, no. 7, 549 pages, 2002. View at Publisher · View at Google Scholar
  44. X. Lin, Q. Zhang, J. R. Rice, D. R. Stewart, D. P. Nowotnik, and S. B. Howell, “Improved targeting of platinum chemotherapeutics: the antitumour activity of the HPMA copolymer platinum agent AP5280 in murine tumour models,” European Journal of Cancer, vol. 40, no. 2, 291 pages, 2004. View at Publisher · View at Google Scholar
  45. J. M. Rademaker-Lakhai, C. Terret, S. B. Howell et al., “A phase I and pharmacological study of the platinum polymer AP5280 given as an intravenous infusion once every 3 weeks in patients with solid tumors,” Clinical Cancer Research, vol. 10, no. 10, 3386 pages, 2004. View at Publisher · View at Google Scholar · View at PubMed
  46. J. Bariyanga, “Synthesis, characterization and biodegradability of poly(ethylene glycol)-bound molecule platinum complex containing ferrocenyl moiety using MALDI time-of-flight mass spectrometry,” Journal of Bioactive and Compatible Polymers, vol. 17, no. 1, 37 pages, 2002. View at Publisher · View at Google Scholar
  47. E. W. Neuse, N. Mphephu, H. M. Netshifhefhe, and M. T. Johnson, “Synthesis and preliminary in vitro evaluation of polymeric dicarboxylato- and dihydroxylatoplatinum(II) chelates as antiproliferative agents,” Polymers for Advanced Technologies, vol. 13, no. 10–12, 884 pages, 2002. View at Publisher · View at Google Scholar
  48. Y. Ohya, S. Shirakawa, M. Matsumoto, and T. Ouchi, “Design of poly(ethylene glycol) immobilizing platinum complex through chelate-type coordination bond,” Polymers for Advanced Technologies, vol. 11, no. 8–12, 635 pages, 2000. View at Publisher · View at Google Scholar
  49. A. K. Andrianov, “Water-soluble polyphosphazenes for biomedical applications,” Journal of Inorganic and Organometallic Polymers and Materials, vol. 16, no. 4, 397 pages, 2006. View at Publisher · View at Google Scholar
  50. Y. S. Sohn, Y. J. Jun, and J. I. Kim, “Tumor selective and biodegradable polyphosphazene-platinum(II) conjugate antitumor agent, and preparation method thereof,” 2005, US Patent no. 6951953. View at Google Scholar
  51. M. T. Johnson, L. L. Komane, D. D. N'Da, and E. W. Neuse, “Polymeric drug carriers functionalized with pairwise arranged hydroxyl and/or carboxyl groups for platinum chelation,” Journal of Applied Polymer Science, vol. 96, no. 1, 10 pages, 2005. View at Publisher · View at Google Scholar
  52. L. Chen, B. Schechter, R. Arnon, and M. Wilchek, “Tissue selective affinity targeting using the avidin-biotin system,” Drug Development Research, vol. 50, no. 3–4, 258 pages, 2000. View at Google Scholar
  53. M. Rosenblum, Chemistry of the Iron Group Metallocenes, Part I, Wiley-Interscience, New York, NY, USA, 1965.
  54. E. W. Neuse and H. Rosenberg, Metallocence Polymers, Marcel Dekker, New York, NY, USA, 1970.
  55. E. W. Neuse, “Polymeric organoiron compounds as prodrugs in cancer research,” Macromolecular Symposia, vol. 172, 127 pages, 2001. View at Publisher · View at Google Scholar
  56. E. W. Neuse, “Polymeric ferrocene conjugates as antiproliferative agents,” in Macromolecules Containing Metal and Metal-Like Elements, Volume 3, Biomedical Applications, A. S. Abd-El-Aziz, C. E. Carraher, Jr., C. U. Pittman, Jr., J. E. Sheats, and M. Zeldin, Eds., p. 89, John Wiley & Sons, New York, NY, USA, 2004, chapter 6. View at Google Scholar
  57. E. W. Neuse, “Macromolecular ferrocene compounds as cancer drug models,” Journal of Inorganic and Organometallic Polymers, vol. 15, no. 1, 3 pages, 2005. View at Publisher · View at Google Scholar
  58. E. W. Neuse, “Metallocene Polymers,” Encyclopedia of Polymer Science Technology, vol. 8, 667 pages, 1968. View at Google Scholar
  59. E. W. Neuse, “Ferrocene Polymers,” Advances in Macromolecular Chemistry, vol. 1, 1 pages, 1968. View at Google Scholar
  60. E. W. Neuse, “Polymetallocenylenes-recent developments,” Journal of Macromolecular Science, Part A, vol. A16, no. 1, 3 pages, 1981. View at Publisher · View at Google Scholar
  61. E. W. Neuse and C. W. N. Mbonyana, “Synthesis of polyaspartamide-bound Ferrocene compounds,” in Inorganic and Metal-Containing Polymeric Materials, J. Sheats, C. Carraher, C. Pittman, M. Zeldin, and B. Currell, Eds., p. 139, Plenum Press, New York, NY, USA, 1990. View at Google Scholar
  62. N. F. Blom, E. W. Neuse, and H. G. Thomas, “Electrochemical characterization of some ferrocenylcarboxylic acids,” Transition Metal Chemistry, vol. 12, no. 4, 301 pages, 1987. View at Publisher · View at Google Scholar
  63. J. C. Swarts, E. W. Neuse, and G. J. Lamprecht, “Synthesis and characterization of water-soluble polyaspartamide-ferrocene conjugates for biomedical applications,” Journal of Inorganic and Organometallic Polymers, vol. 4, no. 2, 143 pages, 1994. View at Publisher · View at Google Scholar
  64. J. C. Swarts, D. M. Swarts, D. M. Maree, E. W. Neuse, C. La Madeleine, and J. E. van Lier, “Polyaspartamides as water-soluble drug carriers. Part 1: antineoplastic activity of ferrocene-containing polyaspartamide conjugates,” Anticancer Research, vol. 21, no. 3B, 2033 pages, 2001. View at Google Scholar
  65. M. T. Johnson, E. Kreft, D. D. N'Da, E. W. Neuse, and C. E. J. van Rensburg, “The cytotoxic activity of macromolecular ferrocene conjugates against the Colo 320 DM human colon cancer line,” Journal of Inorganic and Organometallic Polymers, vol. 13, no. 4, 255 pages, 2003. View at Publisher · View at Google Scholar
  66. D. D. N'Da and E. W. Neuse, “Polyamidoamines as drug carriers: synthesis of polymers featuring extrachain-type primary amino groups as drug-anchoring sites,” South African Journal of Chemistry, vol. 59, 65 pages, 2006. View at Google Scholar
  67. M. G. Meirim, E. W. Neuse, and G. Caldwell, “Water-soluble polymer-ferrocene conjugates based on polyamide carriers containing intrachain-type secondary amine functions as binding sites,” Journal of Inorganic and Organometallic Polymers, vol. 8, no. 4, 225 pages, 1998. View at Publisher · View at Google Scholar
  68. E. W. Neuse, M. G. Meirim, D. D. N'Da, and G. Caldwell, “Polymer-ferrocene conjugates containing an ester function in the connecting links,” Journal of Inorganic and Organometallic Polymers, vol. 9, no. 4, 221 pages, 1999. View at Publisher · View at Google Scholar
  69. B. Schechter, G. Caldwell, and E. W. Neuse, “A preliminary study of the toxicological properties of selected polymer-ferrocene conjugates,” Journal of Inorganic and Organometallic Polymers, vol. 10, no. 4, 177 pages, 2000. View at Publisher · View at Google Scholar